Next Article in Journal
Role of Telomerase in the Cardiovascular System
Next Article in Special Issue
Willing to Be Involved in Cancer
Previous Article in Journal
Telomerase Activity is Downregulated Early During Human Brain Development
Previous Article in Special Issue
The Regulatory Role of KIBRA and PTPN14 in Hippo Signaling and Beyond
Article Menu

Export Article

Open AccessReview
Genes 2016, 7(6), 28; doi:10.3390/genes7060028

The MST/Hippo Pathway and Cell Death: A Non-Canonical Affair

Systems Biology Ireland, University College Dublin, Belfield, Dublin 4, Ireland
School of Medicine and Medical Science, University College Dublin, Belfield, Dublin 4, Ireland
Equal contribution.
Author to whom correspondence should be addressed.
Academic Editor: Paul Reynolds
Received: 10 May 2016 / Revised: 7 June 2016 / Accepted: 9 June 2016 / Published: 17 June 2016
(This article belongs to the Special Issue Hippo Signaling Pathway)
View Full-Text   |   Download PDF [1270 KB, uploaded 17 June 2016]   |  


The MST/Hippo signalling pathway was first described over a decade ago in Drosophila melanogaster and the core of the pathway is evolutionary conserved in mammals. The mammalian MST/Hippo pathway regulates organ size, cell proliferation and cell death. In addition, it has been shown to play a central role in the regulation of cellular homeostasis and it is commonly deregulated in human tumours. The delineation of the canonical pathway resembles the behaviour of the Hippo pathway in the fly where the activation of the core kinases of the pathway prevents the proliferative signal mediated by the key effector of the pathway YAP. Nevertheless, several lines of evidence support the idea that the mammalian MST/Hippo pathway has acquired new features during evolution, including different regulators and effectors, crosstalk with other essential signalling pathways involved in cellular homeostasis and the ability to actively trigger cell death. Here we describe the current knowledge of the mechanisms that mediate MST/Hippo dependent cell death, especially apoptosis. We include evidence for the existence of complex signalling networks where the core proteins of the pathway play a central role in controlling the balance between survival and cell death. Finally, we discuss the possible involvement of these signalling networks in several human diseases such as cancer, diabetes and neurodegenerative disorders. View Full-Text
Keywords: Hippo pathway; signalling network; apoptosis; cancer; diabetes; neurodegenerative disease; YAP; MST1/2; LAST1/2; RASSF1A Hippo pathway; signalling network; apoptosis; cancer; diabetes; neurodegenerative disease; YAP; MST1/2; LAST1/2; RASSF1A

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Fallahi, E.; O’Driscoll, N.A.; Matallanas, D. The MST/Hippo Pathway and Cell Death: A Non-Canonical Affair. Genes 2016, 7, 28.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Genes EISSN 2073-4425 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top